Baird analyst Catherine Schulte reiterated an Outperform rating and $48.00 price target on Twist Bioscience (NASDAQ: TWST).The analyst commented: "November ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE